Brain+
Brain+ is a pioneer in developing Digital Therapeutics (DTx) products for treating and detecting Alzheimer’s and dementia. Digital Therapeutics are clinically validated, regulated and reimbursed medical products, on par with traditional drug treatments, only delivered digitally.
Currently, 1 in 3 seniors die with/of dementia in the US and globally 50 million people are diagnosed with dementia. This figure is expected to more than triple to 152 million people by 2050.